Pg. Oconnor et Jh. Samet, THE SUBSTANCE-USING HUMAN-IMMUNODEFICIENCY-VIRUS PATIENT - APPROACHESTO OUTPATIENT MANAGEMENT, The American journal of medicine, 101(4), 1996, pp. 435-444
Individuals with a substance use disorder who are infected with human
immunodeficiency virus (HIV) provide physicians with challenging issue
s for both medical management and drug treatment. Using a case present
ation format, we present an overview of some of the major issues invol
ved in delivering effective primary care for these individuals. A deta
iled medical and substance use history is critical to sort common comp
laints that can be seen both in HIV infection and with drug use. Physi
cians must be able to recognize withdrawal syndromes and differentiate
those signs and symptoms that may be attributed to specific drugs. A
two-phase model of drug abuse treatment takes into account both detoxi
fication and maintenance of abstinence. Primary care physicians should
be able to initiate the process of substance abuse treatment and refe
r the patient to appropriate substance abuse programs when necessary.
Pharmacological approaches to long-term abstinence with heroin addicti
on include methadone, LAAM, and naltrexone. While clinically challengi
ng, HIV-infected substance users can be successfully managed using the
general principles of primary care.